Quantinuum Stock Debuts, Wall Street Analysts Issue Buy Ratings

Quantinuum, a quantum computing company, began trading on the New York Stock Exchange earlier this month. The stock experienced some volatility on its first day, but several Wall Street analysts have since initiated coverage with buy ratings.

Listing Details

Quantinuum listed on the NYSE under the ticker QNTM after completing a merger with a special purpose acquisition company (SPAC). The company raised approximately $300 million from the deal.

Analyst Recommendations

Several investment banks have issued initial coverage reports, all with buy ratings. Among them:

• Morgan Stanley: Price target $30.
• Goldman Sachs: Price target $28.
• JPMorgan: Price target $32.

Analysts believe Quantinuum possesses advanced quantum computing technology, with strong partnerships including Honeywell and IBM, giving it a competitive edge.

Context

The analyst coverage comes amid growing investor interest in the quantum computing sector, with expectations that the technology will become pivotal in areas such as cryptography and drug discovery. However, revenues remain limited and the company is not yet profitable.

What This Means for Investors

The buy ratings reflect confidence in Quantinuum's long-term prospects, but investors should consider the risks associated with deep-tech startups, including revenue uncertainty and competition.